Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apitegromab with tirzepatide in overweight and obesity
NCT06445075Phase 2Completed
- Sponsor
- Scholar Rock
- Start
- May 2024
- Primary completion
- Mar 2025
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of apitegromab in obesity, sponsored by Scholar Rock. Started May 2024; status: completed.
02
Drugs
apitegromab
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06445075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06445075.